Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (32)
Swathi Prakash, Jared Bies, Mariam Hassan, Adriana Mares & S. Claudia Didia. (2023) Portal vein thrombosis in cirrhosis: A literature review. Frontiers in Medicine 10.
Crossref
Crossref
Hitoshi Maruyama, Maki Tobari, Hiroaki Nagamatsu, Suichiro Shiina & Tadashi Yamaguchi. (2022) Contrast-enhanced ultrasonography for the management of portal hypertension in cirrhosis. Frontiers in Medicine 9.
Crossref
Crossref
Aitor Odriozola, Ángela Puente, Antonio Cuadrado, Coral Rivas, Ángela Anton, Francisco José González, Raúl Pellón, Emilio Fábrega, Javier Crespo & José Ignacio Fortea. (2022) Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive Review. Journal of Clinical Medicine 11:21, pages 6435.
Crossref
Crossref
Jiahui Pan, Le Wang, Fangbo Gao, Yang An, Yue Yin, Xiaozhong Guo, Filipe Gaio Nery, Eric M. Yoshida & Xingshun Qi. (2022) Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis. European Journal of Internal Medicine 104, pages 21-32.
Crossref
Crossref
Sarra Boukhris, Nabil Ben Chaabane, Nader Slama, Arwa Guediche, Leila Safer & Mohamed Adnene Laatiri. (2022) Thrombose porte : quand prescrire un traitement anticoagulant ?. La Presse Médicale Formation 3:3, pages 199-210.
Crossref
Crossref
Yong Lv & Guohong Han. 2022. Portal Hypertension VII. Portal Hypertension VII
507
514
.
Klaus Görlinger, Tetsuro Sakai, Daniel Dirkmann, Raymond M. Planinsic, Khaled Yassen & Fuat H. Saner. 2021. Management of Bleeding Patients. Management of Bleeding Patients
339
359
.
Oana Nicoară-Farcău, Guillem SoyMarta MagazAnna BaigesFanny TuronAngeles Garcia-Criado, Marta Barrufet, Marta Burrel, Virginia Hernández-GeaJuan Carlos García-Pagán. (2020) New Insights into the Pathogenesis, Risk Factors, and Treatment of Portal Vein Thrombosis in Patients with Cirrhosis. Seminars in Thrombosis and Hemostasis 46:06, pages 673-681.
Crossref
Crossref
Jae Young Lee, Yasunori Minami, Byung Ihn Choi, Won Jae Lee, Yi-Hong Chou, Woo Kyoung Jeong, Mi-Suk Park, Nobuki Kudo, Min Woo Lee, Ken Kamata, Hiroko Iijima, So Yeon Kim, Kazushi Numata, Katsutoshi Sugimoto, Hitoshi Maruyama, Yasukiyo Sumino, Chikara Ogawa, Masayuki Kitano, Ijin Joo, Junichi Arita, Ja-Der Liang, Hsi-Ming Lin, Christian Nolsoe, Odd Helge Gilja & Masatoshi Kudo. (2020) The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid. Ultrasonography 39:3, pages 191-220.
Crossref
Crossref
Takehiro Hayashi, Hajime Takatori, Rika Horii, Kouki Nio, Takeshi Terashima, Noriho Iida, Masaaki Kitahara, Tetsuro Shimakami, Kuniaki Arai, Kazuya Kitamura, Kazunori Kawaguchi, Taro Yamashita, Yoshio Sakai, Tatsuya Yamashita, Eishiro Mizukoshi, Masao Honda, Tadashi Toyama, Kenichiro Okumura, Kazuto Kozaka & Shuichi Kaneko. (2019) Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients. BMC Gastroenterology 19:1.
Crossref
Crossref
E. S. Eniseeva. (2019) Anticoagulation in Patients with Liver Cirrhosis (Literature Review). Acta Biomedica Scientifica (East Siberian Biomedical Journal) 4:2, pages 23-28.
Crossref
Crossref
Shigehiro Kokubu. 2019. Clinical Investigation of Portal Hypertension. Clinical Investigation of Portal Hypertension
481
484
.
Daniel Dirkmann. 2019. Critical Care for Potential Liver Transplant Candidates. Critical Care for Potential Liver Transplant Candidates
101
118
.
Hitoshi Maruyama & Naoya Kato. 2018. Diagnostic Methods for Cirrhosis and Portal Hypertension. Diagnostic Methods for Cirrhosis and Portal Hypertension
149
158
.
Ameet Dhar, Benjamin H. Mullish & Mark R. Thursz. (2017) Anticoagulation in chronic liver disease. Journal of Hepatology 66:6, pages 1313-1326.
Crossref
Crossref
Andrea Mancuso. (2017) Portal Vein Thrombosis and Cirrhosis: The Role of Anticoagulation. Current Hepatology Reports 16:2, pages 158-163.
Crossref
Crossref
Filippo Leonardi, Nicola De Maria & Erica Villa. (2017) Anticoagulation in cirrhosis: a new paradigm?. Clinical and Molecular Hepatology 23:1, pages 13-21.
Crossref
Crossref
J. Lakhoo & R.C. Gaba. (2016) Outcomes of transjugular intrahepatic portosystemic shunt creation for flow-enabled dissolution of spleno-mesenterico-portal venous thrombosis. Diagnostic and Interventional Imaging 97:11, pages 1085-1093.
Crossref
Crossref
Hitoshi Maruyama, Gamal Shiha, Osamu Yokosuka, Ashish Kumar, Barjesh Chander Sharma, Alaa Ibrahim, Vivek Saraswat, Cosmas Rinaldi A. Lesmana & Masao Omata. (2015) Non-invasive assessment of portal hypertension and liver fibrosis using contrast-enhanced ultrasonography. Hepatology International 10:2, pages 267-276.
Crossref
Crossref
Hui Chen, Fanny Turon, Virginia Hernández‐Gea, Josep Fuster, Angeles Garcia‐Criado, Marta Barrufet, Anna Darnell, Constantino Fondevila, Juan Carlos Garcia‐Valdecasas & Juan Carlos Garcia‐Pagán. (2016) Nontumoral portal vein thrombosis in patients awaiting liver transplantation. Liver Transplantation 22:3, pages 352-365.
Crossref
Crossref
Aditya M Sharma, Daisy Zhu & Zachary Henry. (2015) Portal vein thrombosis: When to treat and how?. Vascular Medicine 21:1, pages 61-69.
Crossref
Crossref
Hui Chen, Lei Liu, Xingshun Qi, Chuangye He, Feifei Wu, Daiming Fan & Guohong Han. (2016) Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis. European Journal of Gastroenterology & Hepatology 28:1, pages 82-89.
Crossref
Crossref
Klaus Görlinger, Tetsuro Sakai, Daniel Dirkmann, Raymond M. Planinsic & Fuat H. Saner. 2016. Management of Bleeding Patients. Management of Bleeding Patients
263
280
.
Salvador Augustin, Agustin Albillos, Cristina Ripoll, Juan G. Abraldes, Francesco Salerno, Richard Moreau, Thomas Reiberger & Guadalupe Garcia-Tsao. 2016. Portal Hypertension VI. Portal Hypertension VI
341
353
.
Shao-bo Cui, Rong-hua Shu, Shi-ping Yan, Hao Wu, Yong Chen, Le Wang & Qiang Zhu. (2015) Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B. European Journal of Gastroenterology & Hepatology 27:8, pages 914-919.
Crossref
Crossref
Nicolas M. Intagliata, Zachary H. Henry & Patrick G. Northup. (2015) Portal Vein Thrombosis in Patients with Cirrhosis—Etiology, Diagnosis, and Management. Current Hepatology Reports 14:1, pages 1-8.
Crossref
Crossref
Xingshun Qi, Valerio De Stefano, Hongyu Li, Junna Dai, Xiaozhong Guo & Daiming Fan. (2015) Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis of observational studies. European Journal of Internal Medicine 26:1, pages 23-29.
Crossref
Crossref
Klaus Görlinger, Eva Schaden & Fuat H. Saner. 2015. Perioperative Hemostasis. Perioperative Hemostasis
267
283
.
Xingshun Qi, Guohong Han & Daiming Fan. (2014) Management of portal vein thrombosis in liver cirrhosis. Nature Reviews Gastroenterology & Hepatology 11:7, pages 435-446.
Crossref
Crossref
Covadonga Gómez Cuervo, Otilia Bisbal Pardo & Maria A Pérez-Jacoiste Asín. (2013) Efficacy and safety of the use of heparin as thromboprophylaxis in patients with liver cirrhosis: A systematic review and meta-analysis. Thrombosis Research 132:4, pages 414-419.
Crossref
Crossref
Jimena Muciño-Bermejo, Raúl Carrillo-Esper, Misael Uribe & Nahum Méndez-Sánchez. (2013) Coagulation abnormalities in the cirrhotic patient. Annals of Hepatology 12:5, pages 713-724.
Crossref
Crossref
Stephen E. Congly & Samuel S. Lee. (2013) Portal Vein Thrombosis: Should Anticoagulation Be Used?. Current Gastroenterology Reports 15:2.
Crossref
Crossref